Both CD4 and CD8 T Cells Mediate Equally Effective In Vivo Tumor Treatment When Engineered with a Highly Avid TCR Targeting TyrosinaseTimothy L. Frankel, Richard A. Morgan|The Journal of Immunology|2010Cited by 82
A Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor LesionsThomas Enzler, Timothy L. Frankel|International Journal of Molecular Sciences|2024Cited by 13
Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell PolarizationBrian D. Griffith, Timothy L. Frankel|Cancer Discovery|2025Cited by 1